Geode Capital Management, LLC Nuvation Bio Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,028,692 shares of NUVB stock, worth $11.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,028,692

Previous 3,832,445 5.12%

Holding current value

$11.2 Million

Previous $11.2 Million 17.2%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.3 - $3.83 $451,368 - $751,626	196,247 Added 5.12%	4,028,692 $9.27 Million
Q2 2024 Aug 09, 2024	BUY	$2.58 - $3.69 $1.82 Million - $2.6 Million	705,247 Added 22.55%	3,832,445 $11.2 Million
Q1 2024 May 13, 2024	BUY	$1.46 - $3.97 $118,074 - $321,065	80,873 Added 2.65%	3,127,198 $11.4 Million
Q4 2023 Feb 13, 2024	BUY	$0.96 - $1.53 $140,354 - $223,690	146,203 Added 5.04%	3,046,325 $4.6 Million
Q3 2023 Nov 13, 2023	BUY	$1.26 - $2.1 $213,459 - $355,765	169,412 Added 6.2%	2,900,122 $3.89 Million
Q2 2023 Aug 11, 2023	BUY	$1.56 - $1.84 $534,198 - $630,080	342,435 Added 14.34%	2,730,710 $4.92 Million
Q1 2023 May 15, 2023	BUY	$1.6 - $2.48 $110,785 - $171,717	69,241 Added 2.99%	2,388,275 $3.96 Million
Q4 2022 Feb 13, 2023	BUY	$1.68 - $2.5 $76,806 - $114,295	45,718 Added 2.01%	2,319,034 $4.45 Million
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $78,323 - $1.09 Million	270,082 Added 13.48%	2,273,316 $5.09 Million
Q2 2022 Aug 12, 2022	SELL	$3.24 - $5.85 $875,567 - $1.58 Million	-270,237 Reduced 11.89%	2,003,234 $6.49 Million
Q1 2022 May 13, 2022	BUY	$4.6 - $8.83 $533,098 - $1.02 Million	115,891 Added 5.37%	2,273,471 $12 Million
Q4 2021 Feb 11, 2022	BUY	$7.75 - $10.05 $5.8 Million - $7.52 Million	748,225 Added 53.09%	2,157,580 $18.3 Million
Q3 2021 Nov 12, 2021	BUY	$7.78 - $10.0 $4.71 Million - $6.05 Million	605,416 Added 75.31%	1,409,355 $14 Million
Q2 2021 Aug 13, 2021	BUY	$9.22 - $14.48 $2.6 Million - $4.09 Million	282,357 Added 54.13%	803,939 $7.48 Million
Q1 2021 May 12, 2021	BUY	$9.0 - $14.57 $4.69 Million - $7.6 Million	521,582 New	521,582 $5.45 Million

Others Institutions Holding NUVB

# of Institutions

158

Shares Held

157M

Call Options Held

3.2K

Put Options Held

98.7K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $604M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Nuvation Bio Inc. Transaction History